analyst
PY
NASDAQ · PYXS
Pyxis Oncology, Inc. Common Stock
Healthcare · Biotechnology
$3.08
Down-$0.04 (-1.28%)
Updated Aug 22, 2026, 8:22 PM
SID Score
6.6/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 274.21M
- P/E ratio
- -2.84
- Dividend yield
- 0.00%
- 52-week range
- $1.03 – $5.55
- Volume
- 682.28K
- Avg. volume
- 793.75K
Price performance
PYXS price history
1M range · 21 trading sessions · Daily adjusted prices
PYXS closed at $3.08 after 21 trading sessions, up 18.01% for the selected period.
- Last close
- $3.08
- Period change
- +18.01%
- Period low
- $2.61
- Period high
- $3.83
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 21, 2026 | $3.15 | $3.21 | $3.02 | $3.08 | 682.28K |
| Aug 20, 2026 | $3.30 | $3.39 | $3.03 | $3.12 | 716.27K |
| Aug 19, 2026 | $3.07 | $3.50 | $3.06 | $3.37 | 1.04M |
| Aug 18, 2026 | $3.03 | $3.13 | $2.97 | $2.99 | 353.48K |
| Aug 17, 2026 | $3.03 | $3.09 | $2.83 | $3.02 | 558.94K |
| Aug 14, 2026 | $2.99 | $3.08 | $2.8616 | $3.01 | 703.83K |
| Aug 13, 2026 | $2.95 | $3.35 | $2.75 | $3.01 | 1.27M |
| Aug 12, 2026 | $2.76 | $3.211 | $2.72 | $3.18 | 1.94M |
| Aug 11, 2026 | $3.85 | $4.00 | $1.90 | $2.83 | 12.12M |
| Aug 10, 2026 | $3.72 | $3.985 | $3.72 | $3.83 | 999.1K |
| Aug 7, 2026 | $3.78 | $3.90 | $3.62 | $3.73 | 1.24M |
| Aug 6, 2026 | $3.14 | $3.77 | $3.13 | $3.75 | 1.4M |
| Aug 5, 2026 | $3.20 | $3.3183 | $3.07 | $3.13 | 668.8K |
| Aug 4, 2026 | $3.02 | $3.25 | $3.02 | $3.16 | 926.19K |
| Aug 3, 2026 | $2.70 | $3.045 | $2.70 | $3.04 | 1.14M |
| Jul 31, 2026 | $2.84 | $2.85 | $2.63 | $2.65 | 750.11K |
| Jul 30, 2026 | $2.95 | $3.00 | $2.805 | $2.87 | 638.48K |
| Jul 29, 2026 | $2.90 | $3.09 | $2.89 | $2.92 | 944.52K |
| Jul 28, 2026 | $2.90 | $3.05 | $2.74 | $2.91 | 1.73M |
| Jul 27, 2026 | $2.64 | $2.99 | $2.62 | $2.91 | 987.74K |
| Jul 24, 2026 | $2.72 | $2.8296 | $2.60 | $2.61 | 855.41K |
Latest PYXS news
The latest Smart Investors Daily articles mentioning PYXS.
Stock researchCompany · Financials
Loading stock research…